CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-22 | Becklund Irene PAO | Sale 10b5-1 | −2,936 | $26.49 | $78K | 5,071 |
| 2025-04-21 | Baird Melissa Chief Operating Officer | Exercise or conversion 10b5-1 | +22,568 | $1.75 | $39K | 827,651 |
| 2025-04-21 | Baird Melissa Chief Operating Officer | Exercise or conversion 10b5-1 | +10,765 | $2.43 | $26K | 838,416 |
| 2025-04-21 | Baird Melissa Chief Operating Officer | Sale 10b5-1 | −27,035 | $25.66 | $694K | 811,381 |
| 2025-04-21 | Baird Melissa Chief Operating Officer | Sale 10b5-1 | −6,298 | $26.29 | $166K | 805,083 |
| 2025-04-21 | Baird Melissa Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −22,568 | 0 | ||
| 2025-04-21 | Baird Melissa Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −10,765 | 727,128 | ||
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +17,001 | $2.43 | $41K | 111,896 |
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +16,667 | $2.43 | $41K | 128,563 |
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −33,668 | $28.02 | $943K | 94,895 |
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,792 | $28.31 | $79K | 92,103 |
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −47,534 | $28.23 | $1.3M | 332,728 |
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −17,001 | 119,011 | ||
| 2025-04-16 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −16,667 | 1,173,066 | ||
| 2025-04-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +1,400 | $11.53 | $16K | 125,504 |
| 2025-04-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +5,037 | $5.01 | $25K | 130,541 |
| 2025-04-15 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $28.50 | $330K | 118,960 |
| 2025-04-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −1,400 | 64,332 | ||
| 2025-04-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −5,037 | 399,296 | ||
| 2025-04-14 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,236 | $28.72 | $93K | 162,898 |
Page 36 of 37 · 739 trades